ey0015.4-6 | New therapeutic options | ESPEYB15
D Harada
, N Namba
, Y Hanioka
, K Ueyama
, N Sakamoto
, Y Nakano
, M Izui
, Y Nagamatsu
, H Kashiwagi
, M Yamamuro
, Y Ishiura
, A Ogitani
, Y Seino
To read the full abstract: Eur J Pediatr 2017; 176:873-879Achondroplasia (ACH) is the most common genetic form of disproportionate short stature, occurring in 1:15,000 –1:40,000 live births [28]. Most patients have a gain of function mutation in the transmembrane domain of the fibroblast growth factor receptor 3 (FGFR3), leading to prolonged intracellular MAPK signalin...